Emergency Medicine Doctors in Snoqualmie, WA Accepting Medicare

7 Emergency Medicine doctors found. Showing 1 - 7

Jonathan Halper, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9801 Frontier Ave Se, Snoqualmie, WA 98065 Phone: 425-831-2300    Fax: 425-831-2361

Karen Betty Tom, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9801 Frontier Ave Se, Snoqualmie, WA 98065 Phone: 425-831-2321    Fax: 425-831-2361

John Todd Huttenlocher, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9801 Frontier Ave Se, Snoqualmie, WA 98065 Phone: 425-831-2300    Fax: 425-831-2361

Alan Richard Chock, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9801 Frontier Ave Se, Snoqualmie, WA 98065 Phone: 425-831-2300    Fax: 425-831-2361

Dr. Charles William Korbonits Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9801 Frontier Ave Se, Emergency Department, Snoqualmie, WA 98065 Phone: 425-831-2323    Fax: 425-831-2329

Jeffrey Carleton Wood, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9575 Ethan Wade Way Se, Snoqualmie, WA 98065 Phone: 425-831-2300    Fax: 425-831-2361

Duane Alan Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9801 Frontier Ave Se, Snoqualmie, WA 98065 Phone: 425-831-2300    Fax: 425-831-1994

News Archive

Researchers identify a new approach for treating brain metastases associated with lung cancer

Lung cancer is the world's most common cause of death from cancer. In Austria, around 4,000 people develop this type of cancer every year. One particular problem is the development of brain metastases in association with the lung tumour.

New biochip technology could eliminate animal testing in chemicals and cosmetics industries

A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.

Landmark clinical trial to test third investigational drug for Alzheimer's disease

An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease.

Scientists use parsley and other plants to create human stem cell scaffolds

Borrowing from nature is an age-old theme in science. Form and function go hand-in-hand in the natural world and the structures created by plants and animals are only rarely improved on by humans.

Read more Medical News

› Verified 7 days ago